Newsom Announces Plan for California to Make Its Own “Cheaper” Insulin

California will manufacture more affordable insulin in a partnership with nonprofit generic drugmaker Civica Rx, Gov. Gavin Newsom announced Saturday during a visit to Southern California. 

The partnership will provide insulin to Californians for $30 per 10 milliliters, the governor said during a stop at a Kaiser warehouse in Downey. The visit is part of a statewide tour to highlight policies — a road trip alternative to the governor’s traditional State of the State address. 

The 10-year partnership will be administered through Cal Rx. Manufacturing is expected to begin later this year with deliveries coming next year, Newsom said.

“This a big deal for us,” Newsom said.

As part of the $50 million contract, Civica will produce three insulins — glargine, lispro and aspart. They will be available in vials and pre-filled pens with the Cal Rx label. 

It was not immediately clear where the products will be manufactured. 

Leave comment

Your email address will not be published. Required fields are marked with *.